Hospira Injectable Drug Products: Recall – Visible Particulates from Defective Glass Vials

by FDA on July 16, 2012

in MedWatch

Symptoms of particulate matter injected into a patient might include bleeding, bruising, inflammation, itching, rash, chest pain and respiratory symptoms.

This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice.

View Full Details Of The Original MedWatch Notice Here.

Bookmark and Share

Leave a Comment

Previous post:

Next post: